| Nilotinib |
ENSG00000104691.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000142396.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000160336.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000174680.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000175147.7 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000175967.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000177406.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000177788.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000178412.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000178803.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000178977.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000180139.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000180279.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000182109.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000182165.13 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000182165.13 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000182165.13 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000182310.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000185186.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000186369.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000188206.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000188660.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000189149.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000189223.9 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000198221.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000198468.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000203362.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000203496.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000203808.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000203875.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000204706.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000204758.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000204815.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000204837.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000204929.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000204934.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000204949.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000205037.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000205293.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000205559.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000206195.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000206417.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000206567.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000212552.2 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000212978.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000213468.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000213863.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000213963.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000213971.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000214049.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000214870.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000215159.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000215241.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000215908.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000217576.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000219665.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000223374.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000223404.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000223461.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000223478.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000223478.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000223522.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000223546.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000223576.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000223598.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000223598.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000223685.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000223695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000223711.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000223784.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000223799.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000224023.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000224031.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000224043.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000224050.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000224078.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000224093.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000224101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000224138.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000224216.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000224281.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000224363.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000224409.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000224505.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000224533.3 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000224614.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000224638.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000224649.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000224699.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000224733.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000224746.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000224761.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000224799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000224846.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000224863.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000224884.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000224885.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000224899.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000224959.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000225030.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000225032.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000225037.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000225063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000225084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000225163.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000225163.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000225177.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000225210.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000225213.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000225335.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000225393.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000225439.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000225442.2 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000225489.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000225675.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000225684.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000225725.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000225725.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000225744.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000225767.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000225778.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000225793.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000225833.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000225836.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000225891.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000225975.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000226047.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000226179.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000226245.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000226332.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000226419.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000226445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000226453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000226609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000226645.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000226649.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000226686.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000226688.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000226690.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000226711.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000226746.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000226751.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000226756.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000226824.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000226851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000226877.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000226904.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000227039.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000227039.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000227071.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000227071.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000227083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000227110.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000227155.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000227161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000227237.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000227245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000227285.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000227409.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000227431.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000227456.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000227484.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000227512.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000227516.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000227540.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000227544.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000227589.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000227603.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000227681.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000227906.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000227945.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000227954.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000227954.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000228021.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000228022.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000228113.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000228115.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000228115.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000228172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000228192.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000228237.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000228242.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000228294.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000228395.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000228412.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000228486.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000228509.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000228526.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000228629.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000228649.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000228719.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000228723.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000228775.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000228826.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000228838.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000228878.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000228906.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000229127.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000229127.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000229153.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000229214.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000229227.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000229267.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000229291.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000229444.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000229487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000229521.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000229582.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000229660.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000229666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000229739.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000229766.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000229807.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000229832.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000229832.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000229841.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000229848.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000229852.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000229867.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000229867.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000229983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000230001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000230046.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000230058.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000230082.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000230102.3 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000230124.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000230289.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000230292.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000230316.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000230337.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000230337.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000230368.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000230433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000230499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000230506.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000230530.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000230550.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000230550.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000230597.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000230612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000230612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000230613.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000230698.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000230732.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000230736.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000230789.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000230881.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000230899.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000230939.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000231010.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000231025.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000231056.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000231081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000231104.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000231104.4 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000231128.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000231154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000231187.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000231201.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000231212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000231252.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000231291.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000231294.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000231329.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000231329.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000231334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000231346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000231453.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000231486.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000231519.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000231530.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000231563.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000231563.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000231563.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000231607.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000231616.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000231628.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000231638.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000231709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000231728.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000231731.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000231734.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000231842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000231948.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000232028.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000232028.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000232043.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000232077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000232093.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000232117.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000232117.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000232124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000232164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000232363.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000232377.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000232442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000232455.2 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000232485.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000232533.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000232545.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000232593.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000232633.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000232686.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000232693.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000232762.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000232811.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000232828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000232860.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000232876.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000232907.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000232907.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000232912.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000232940.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000232956.4 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000232987.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000233008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000233017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000233030.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000233085.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000233086.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000233101.6 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000233221.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000233237.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000233251.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000233330.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000233338.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000233339.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000233461.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000233547.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000233593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000233613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000233654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000233654.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000233695.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000233723.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000233783.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000233785.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000233800.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000233847.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000233847.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000233895.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000233926.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000234050.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000234062.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000234076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000234141.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000234185.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000234252.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000234281.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000234327.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000234327.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000234350.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000234393.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000234427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000234456.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000234509.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000234616.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000234617.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000234630.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000234676.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000234694.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000234694.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000234705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000234773.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000234789.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000234793.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000234899.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000234913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000234915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000235021.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000235029.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000235070.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000235079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000235079.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000235159.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000235237.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000235257.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000235373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000235387.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000235426.2 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000235450.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000235477.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000235495.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000235497.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000235586.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000235609.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000235615.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000235629.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000235643.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000235652.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000235725.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000235740.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000235795.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000235843.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000235904.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000235908.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000235908.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000235947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000235958.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000236008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000236017.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000236051.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000236078.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000236078.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000236088.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000236140.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000236199.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000236200.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000236305.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000236324.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000236345.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000236426.3 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000236432.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000236438.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000236449.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000236463.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000236463.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000236472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000236498.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000236519.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000236535.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000236536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000236537.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000236540.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000236545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000236545.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000236559.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000236760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000236778.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000236780.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000236780.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000236824.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000236833.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000236850.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000236861.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000236869.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000236914.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000236924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000236935.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000236935.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000236935.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000236943.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000236947.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000236983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000237021.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000237126.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000237133.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000237149.4 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000237188.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000237234.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000237331.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000237380.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000237399.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000237424.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000237463.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000237485.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000237489.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000237502.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000237502.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000237513.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000237523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000237594.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000237614.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000237614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000237637.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000237689.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000237689.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000237718.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000237737.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000237738.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000237805.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000237807.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000237807.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000237819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000237877.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000237892.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000237903.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000237927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000238005.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000238009.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000238068.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000238113.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000238123.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000238142.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000238198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000238198.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000238210.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000238260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000238287.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000238291.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000239335.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000239407.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000239498.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000239552.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000239674.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000239674.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000239828.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000239945.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000240207.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000240254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000240288.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000240291.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000240401.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000240423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000240476.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000240499.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000240549.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000240618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000240758.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000240758.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000240766.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000240990.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000241135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000241155.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000241155.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000241163.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000241316.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000241479.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000241544.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000241560.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000241764.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000241769.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000241770.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000241933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000241954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000242104.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000242516.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000242687.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000243069.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000243368.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000243433.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000243701.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000243766.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000243795.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000243926.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000244063.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000244265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000244265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000244268.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000244300.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000244306.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000244459.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000244513.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000244791.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000244952.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000245060.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000245105.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000245148.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000245149.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000245248.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000245311.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000245552.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000245552.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000245614.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000245685.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000245729.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000245869.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000246089.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000246225.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000246323.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000246363.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000246777.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000246859.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000246898.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000247095.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000247157.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000247240.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000247516.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000247516.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000247809.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000247809.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000247925.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000247982.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000248092.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000248174.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000248243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000248367.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000248367.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000248399.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000248537.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000248544.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000248587.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000248663.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000248664.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000248671.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000248719.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000248724.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000248773.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000248774.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000248846.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000248890.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000248968.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000248968.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000248973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000249042.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000249096.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000249159.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000249258.2 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000249304.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000249375.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000249395.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000249451.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000249592.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000249635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000249647.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000249684.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000249685.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000249786.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000249791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000249791.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000249825.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000250027.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000250073.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000250075.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000250106.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000250116.2 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000250133.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000250156.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000250260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000250295.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000250410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000250564.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000250608.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000250786.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000250891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000250909.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000250948.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000250950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000250988.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000251022.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000251131.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000251169.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000251292.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000251292.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000251307.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000251574.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000251615.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000251629.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000251666.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000253112.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000253121.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000253390.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000253390.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000253390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000253392.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000253404.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000253476.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000253549.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000253552.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000253603.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000253641.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000253642.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000253669.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000253669.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000253730.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000253773.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000253829.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000253837.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000253931.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000253986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000253986.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000253986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000254027.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000254028.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000254109.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000254204.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000254205.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000254226.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000254258.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000254263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000254409.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000254427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000254484.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000254485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000254485.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000254530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000254551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000254556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000254560.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000254606.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000254615.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000254664.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000254739.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000254762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000254791.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000254854.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000254900.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000254936.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000254964.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000254988.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000255031.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000255159.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000255164.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000255165.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000255176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000255237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000255306.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000255306.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000255310.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000255322.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000255364.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000255422.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000255435.2 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000255471.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000255509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000255521.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000255580.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000255651.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000255741.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000255790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000255843.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000255857.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000255968.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000255968.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000255983.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000256006.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000256150.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000256314.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000256433.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000256448.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000256564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000256588.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000256588.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000256596.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000256712.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000256747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000256897.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000256943.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000257114.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000257126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000257151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000257176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000257264.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000257279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000257298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000257474.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000257488.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000257497.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000257527.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000257534.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000257556.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000257568.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000257621.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000257647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000257681.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000257681.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000257696.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000257696.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000257711.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000257759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000257824.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000258017.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000258044.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000258048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000258101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000258136.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000258136.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000258137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000258168.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000258172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000258175.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000258188.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000258234.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000258302.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000258402.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000258410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000258424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000258442.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000258443.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000258450.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000258458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000258520.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000258556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000258620.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000258623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000258633.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000258658.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000258682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000258689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000258693.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000258704.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000258752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000258825.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000258891.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000258897.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000259006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000259038.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000259067.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000259070.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000259088.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000259103.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000259138.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000259146.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000259153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000259153.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000259163.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000259206.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000259215.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000259219.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000259230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000259274.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000259275.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000259298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000259336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000259349.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000259364.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000259364.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000259417.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000259450.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000259453.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000259456.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000259469.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000259520.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000259548.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000259583.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000259595.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000259596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000259654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000259723.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000259736.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000259758.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000259826.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000259863.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000259883.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000259920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000259921.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000259953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000259959.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000259986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000260000.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000260022.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000260025.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000260038.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000260065.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000260093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000260093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000260167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260194.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000260219.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000260231.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000260273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000260276.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000260285.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260349.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260349.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260351.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000260352.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000260360.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260361.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000260368.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000260404.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260417.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260418.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000260418.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260447.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000260448.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260470.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260475.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000260493.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000260495.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000260507.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260517.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260579.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260583.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000260589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260591.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260597.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000260608.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000260645.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000260646.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000260660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000260661.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000260664.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260671.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260672.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000260693.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000260698.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260735.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000260743.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000260743.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000260766.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000260778.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000260778.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260790.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260793.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000260796.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000260803.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260804.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260814.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000260831.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000260833.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000260877.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000260896.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260917.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000260917.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000260920.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000260920.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260923.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000260938.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000260971.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000260988.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000260988.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000261000.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000261008.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000261015.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000261040.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000261096.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000261105.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000261105.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000261118.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000261124.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000261131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000261186.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000261189.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000261207.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000261216.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000261251.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000261273.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000261288.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000261327.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000261341.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000261357.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000261373.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000261386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000261396.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000261416.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000261428.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000261433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000261460.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000261471.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000261471.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000261476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000261490.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000261496.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000261505.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000261521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000261533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000261542.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000261544.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000261544.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000261572.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000261574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000261578.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000261584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000261613.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000261613.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000261697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000261744.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000261760.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000261783.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000261823.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000261840.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000261842.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000261864.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000261888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000262074.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000262115.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000262147.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000262202.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000262222.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000262228.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000262296.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000262362.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000262372.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000262668.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000262703.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000262833.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000262873.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000262944.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000262979.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000263013.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000263033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000263050.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000263069.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000263214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000263293.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000263338.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000263345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000263393.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000263412.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000263443.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000263466.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000263627.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000263718.2 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000263916.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000263975.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000264007.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000264078.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000264339.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000264433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000264469.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000264514.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000264546.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000264546.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000264673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000264729.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000264868.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000265010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000265094.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000265218.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000265242.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000265625.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000265801.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000265845.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000265888.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000265912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000265943.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000266126.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000266283.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000266289.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000266371.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000266446.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000266541.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000266541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000266579.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000266644.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000266709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000266709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000266717.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000266805.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000266912.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000266921.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000266934.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000266935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000266942.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000266957.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000266999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000267003.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000267011.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000267018.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000267024.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000267069.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000267095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000267096.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000267128.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000267163.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000267212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000267222.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000267230.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000267247.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000267255.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000267273.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000267287.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000267289.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000267298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000267299.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000267302.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000267308.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000267344.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000267348.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000267373.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000267374.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000267383.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000267405.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000267476.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000267481.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000267505.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000267519.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000267522.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000267532.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000267577.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000267586.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000267637.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000267637.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000267638.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000267651.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000267654.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000267711.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000267751.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000267764.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000267778.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000267798.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000267798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000267834.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000267834.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000267871.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000267874.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000267922.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000268001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000268001.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000268015.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000268015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000268015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000268015.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000268061.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000268095.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000268186.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000268189.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000268204.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000268289.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000268307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000268340.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000268520.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000268564.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000268833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000268938.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000268945.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000268970.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000268970.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000269102.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000269148.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000269161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000269202.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000269290.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000269397.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000269444.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000269487.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000269534.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000269574.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000269600.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000269600.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000269653.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000269653.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000269802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000269903.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000269911.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000269918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000269934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000269938.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000269938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000269946.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000269946.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000269956.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000269983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000269997.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000269999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000270006.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000270012.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000270015.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000270018.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000270019.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000270019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000270048.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000270049.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000270055.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000270060.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000270061.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000270062.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000270066.2 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000270067.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000270074.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000270084.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000270095.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000270104.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000270109.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000270115.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000270117.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000270124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000270140.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000270143.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000270168.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000270174.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000270189.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000270189.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000270190.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000270223.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000270246.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000270265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000270332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000270426.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000270462.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000270522.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000270557.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000270571.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000270604.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000270641.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000270681.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000270704.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000270726.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000270951.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000271109.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000271119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000271119.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000271127.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000271133.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000271270.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000271327.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000271401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000271590.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000271590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000271737.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000271742.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000271752.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000271757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000271761.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000271778.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000271789.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000271833.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000271843.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000271889.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000271889.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000271911.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000271914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000271963.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000271967.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000271973.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000271975.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000271983.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000271991.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000271993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000271993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000271997.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272005.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000272024.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000272024.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000272057.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000272070.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000272076.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272079.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272088.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000272092.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000272094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272102.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000272103.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000272129.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000272144.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000272198.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000272198.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000272198.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000272205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000272211.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000272264.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272361.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000272368.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000272372.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000272403.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000272430.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000272452.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272452.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000272457.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272482.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272485.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000272505.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272508.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000272520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000272520.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000272549.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272574.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000272574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272604.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000272609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272659.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272659.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000272662.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000272662.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000272691.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000272692.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000272721.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272734.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000272744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000272745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272746.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000272764.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000272777.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000272825.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000272846.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272862.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272872.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272902.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000272905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272913.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000272914.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000272917.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272931.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000272933.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000272940.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000272940.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000272966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272970.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272971.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272977.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000272977.1 |
Predicted lncRNA |
Sarcoma |
|
| Nilotinib |
ENSG00000272979.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000272983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000272983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000272983.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000273001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000273004.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000273014.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000273014.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000273017.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000273019.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000273019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000273026.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000273032.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000273038.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000273059.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000273061.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000273061.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000273066.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000273071.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000273077.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000273081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000273084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000273108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000273113.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Nilotinib |
ENSG00000273131.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000273133.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Nilotinib |
ENSG00000273133.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000273156.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000273162.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000273164.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000273174.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Nilotinib |
ENSG00000273186.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Nilotinib |
ENSG00000273190.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Nilotinib |
ENSG00000273198.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000273240.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000273247.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000273271.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
ENSG00000273290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Nilotinib |
ENSG00000273329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000273366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000273367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000273402.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Nilotinib |
ENSG00000273406.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000273424.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000273428.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Nilotinib |
ENSG00000273445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Nilotinib |
ENSG00000273447.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Nilotinib |
miR-17 |
Curated miRNA |
chronic myeloid leukemia |
|